Lead sponsor
Medivation, Inc.
7 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
7
Trials led
0
Ongoing
2,641
Total enrollment
125
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 2
2
Phase 3
4
Trials by status
Completed
4
Terminated
3
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's DiseaseAlzheimer's diseasePh 2Completed183
Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's DiseaseAlzheimer's diseasePh 2Terminated50
Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus DonepezilAlzheimer's diseasePh 1Completed46